ÔçÒÒŮѸÀ×

    1. <form id=SSjMaZxIp><nobr id=SSjMaZxIp></nobr></form>
      <address id=SSjMaZxIp><nobr id=SSjMaZxIp><nobr id=SSjMaZxIp></nobr></nobr></address>

      Passive Biotech

      Invesco Biotechnology & Genome ETF

      The Invesco Biotechnology & Genome ETF (the ¡°Fund¡±) seeks to track the investment results (before fees and expenses) of the Dynamic Biotech & Genome Intellidex??Index (the ¡°Underlying Index¡±).

      $70.15

      Compare similar ETFs

      Fund Size
      Dividend
      Fees
      Current
      Biotechnology & Genome ETF PBE
      Fund Size
      $244M
      Dividend
      0.2%
      Fees
      -
      Total Stock Market Index Fund VTSAX
      Fund Size
      $1.7T
      Dividend
      -
      Fees
      -
      Total Stock Market Index Fund VTI
      Fund Size
      $1.7T
      Dividend
      1.2%
      Fees
      0.03%
      500 Index Fund VFIAX
      Fund Size
      $1.49T
      Dividend
      -
      Fees
      -
      500 Index Fund VOO
      Fund Size
      $1.49T
      Dividend
      1.2%
      Fees
      0.03%
      View 1315 similar ETFs →

      Average metrics of all companies in portfolio

      Compare to
      Market
      Market Cap The market value of the company. It's calculated by multiplying the share price by the number of outstanding shares. $29.1B
      Dividend Yield Yearly payout to shareholders per share. The percentage indicates the payout in relation to the share price. 0.36 %
      Beta Indicates the relationship between the price performance of a share and the market. 0.7541
      P/E Ratio Ratio between share price and earnings per share. A low ratio could indicate that the stock is undervalued or investors aren't expecting high growth. A high ratio could indicate that the stock is overvalued or investors are expecting high growth. 117.49
      Negative P/E Ratio a negative P/E ratio shows that the company is not profitable, and it shows how many years it would take the company to lose its entire market capitalisation if it did not change anything -20.86
      Profitable Companies 64
      PEG The ratio between the P/E ratio and the growth rate of the company's earnings per share in the last twelve months. A lower PEG could mean that a stock is undervalued. 131.91
      Price to Sales Ratio Market cap divided by the revenue in the most recent year. 6.95
      Price to Book Ratio Price to Book Ratio is the Market cap divided by the Book value of the company 6.15
      Compare to
      Market
      Enterprise Value to EBIT Enterprise Value divided by EBIT 23.86
      Enterprise Value to Revenue Enterprise value divided by revenue 5.71
      Total Debt to Enterprise Value Total debt divided by enterprise value 0.1
      Debt to Equity A higher ratio indicates a higher risk. However, the ratio is difficult to compare between industries where common amounts of debt vary. 1.0075
      Profit Margin Net income divided by revenue of the last 4 quarters. It indicates the company's profitability. -16.56%
      Quarterly Earnings Growth (YoY) The rate at which the company's net income has increased to the same quarter one year ago. -
      Return on Equity Equity divided by market cap. 22.81%
      Return on Assets Indicates a company's profitability in relation to its total assets. -4.99%
      Return on Invested Capital Return on invested capital (ROIC) is net income after dividends divided by the sum of debt and equity. It shows how effective a company is at turning capital invested by shareholders and other debtholders into profits. 2.01%

      Industries

      Healthcare 90.9%
      N/A 9.1%

      Market cap

      Micro Cap 2%
      Small Cap 28%
      Mid Cap 21%
      Large Cap 48%
      Mega Cap 0%

      33 Investments

      P/E-Ratio
      Total Investment
      Weight
      Invesco Private Prime Fund logo

      Invesco Private Prime Fund

      P/E-Ratio
      n/a
      Total Investment
      $16.3M
      Weight
      7.4%
      Natera, Inc. logo

      NTRA - Health Care and Social Assistance

      Natera, Inc.

      P/E-Ratio
      -90.6
      Total Investment
      $11.5M
      Weight
      5.2%
      Gilead Sciences, Inc. logo

      GILD - Manufacturing

      Gilead Sciences, Inc.

      P/E-Ratio
      22.3
      Total Investment
      $11.3M
      Weight
      5.1%
      Neurocrine Biosciences, Inc. logo

      NBIX - Manufacturing

      Neurocrine Biosciences, Inc.

      P/E-Ratio
      39.7
      Total Investment
      $11M
      Weight
      5.0%
      Amgen Inc. logo

      AMGN - Manufacturing

      Amgen Inc.

      P/E-Ratio
      23.4
      Total Investment
      $10.9M
      Weight
      4.9%
      TG Therapeutics, Inc. logo

      TGTX - Manufacturing

      TG Therapeutics, Inc.

      P/E-Ratio
      71.2
      Total Investment
      $10.1M
      Weight
      4.5%
      United Therapeutics Corp. logo

      UTHR - Manufacturing

      United Therapeutics Corp.

      P/E-Ratio
      11.1
      Total Investment
      $10M
      Weight
      4.5%
      Biogen Inc. logo

      BIIB - Manufacturing

      Biogen Inc.

      P/E-Ratio
      12.6
      Total Investment
      $10M
      Weight
      4.5%
      Regeneron Pharmaceuticals, Inc. logo

      REGN - Manufacturing

      Regeneron Pharmaceuticals, Inc.

      P/E-Ratio
      13.7
      Total Investment
      $9.8M
      Weight
      4.4%
      Illumina, Inc. logo

      ILMN - Manufacturing

      Illumina, Inc.

      P/E-Ratio
      12.6
      Total Investment
      $9.6M
      Weight
      4.3%
      Protagonist Therapeutics, Inc. logo

      PTGX - Manufacturing

      Protagonist Therapeutics, Inc.

      P/E-Ratio
      72.1
      Total Investment
      $8.44M
      Weight
      3.8%
      Catalyst Pharmaceuticals, Inc. logo

      CPRX - Manufacturing

      Catalyst Pharmaceuticals, Inc.

      P/E-Ratio
      12.1
      Total Investment
      $7.54M
      Weight
      3.4%
      Qiagen N.V. logo

      QGEN - Manufacturing

      Qiagen N.V.

      P/E-Ratio
      27.0
      Total Investment
      $6.95M
      Weight
      3.1%
      BioCryst Pharmaceuticals, Inc. logo

      BCRX - Manufacturing

      BioCryst Pharmaceuticals, Inc.

      P/E-Ratio
      -48.7
      Total Investment
      $6.9M
      Weight
      3.1%
      Exelixis, Inc. logo

      EXEL - Professional, Scientific, and Technical Services

      Exelixis, Inc.

      P/E-Ratio
      16.9
      Total Investment
      $6.84M
      Weight
      3.1%
      Halozyme Therapeutics, Inc. logo

      HALO - Manufacturing

      Halozyme Therapeutics, Inc.

      P/E-Ratio
      15.9
      Total Investment
      $6.84M
      Weight
      3.1%
      PTC Therapeutics, Inc. logo

      PTCT - Manufacturing

      PTC Therapeutics, Inc.

      P/E-Ratio
      6.1
      Total Investment
      $6.39M
      Weight
      2.9%
      Blueprint Medicines Corp. logo

      BPMC - Manufacturing

      Blueprint Medicines Corp.

      P/E-Ratio
      -52.9
      Total Investment
      $6.34M
      Weight
      2.9%
      Invesco Private Government Fund logo

      Invesco Private Government Fund

      P/E-Ratio
      n/a
      Total Investment
      $6.31M
      Weight
      2.9%
      Royalty Pharma PLC logo

      RPRX - Manufacturing

      Royalty Pharma PLC

      P/E-Ratio
      14.9
      Total Investment
      $6.29M
      Weight
      2.8%
      Collegium Pharmaceutical, Inc. logo

      COLL - Manufacturing

      Collegium Pharmaceutical, Inc.

      P/E-Ratio
      34.0
      Total Investment
      $6.05M
      Weight
      2.7%
      Veracyte, Inc. logo

      VCYT - Health Care and Social Assistance

      Veracyte, Inc.

      P/E-Ratio
      90.1
      Total Investment
      $5.88M
      Weight
      2.7%
      Exact Sciences Corp. logo

      EXAS - Professional, Scientific, and Technical Services

      Exact Sciences Corp.

      P/E-Ratio
      -8.9
      Total Investment
      $5.87M
      Weight
      2.7%
      BioMarin Pharmaceutical Inc. logo

      BMRN - Manufacturing

      BioMarin Pharmaceutical Inc.

      P/E-Ratio
      17.0
      Total Investment
      $5.78M
      Weight
      2.6%
      MannKind Corp. logo

      MNKD - Manufacturing

      MannKind Corp.

      P/E-Ratio
      42.7
      Total Investment
      $5.76M
      Weight
      2.6%
      HoMEÔçÒÒŮѸÀ×